These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17224734)

  • 1. Inhibition of selective noradrenergic reuptake as treatment of pathological laughter.
    Møller M; Andersen G
    J Clin Psychopharmacol; 2007 Feb; 27(1):108-10. PubMed ID: 17224734
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.
    Nahas Z; Arlinghaus KA; Kotrla KJ; Clearman RR; George MS
    J Neuropsychiatry Clin Neurosci; 1998; 10(4):453-5. PubMed ID: 9813792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Du rire aux larmes: pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine.
    Chahine LM; Chemali Z
    Epilepsy Behav; 2006 May; 8(3):610-5. PubMed ID: 16504590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic laughing and intractable hiccups can occur early in multiple sclerosis.
    de Seze J; Zephir H; Hautecoeur P; Mackowiak A; Cabaret M; Vermersch P
    Neurology; 2006 Nov; 67(9):1684-6. PubMed ID: 17101907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A real reason for patients with pseudobulbar affect to smile.
    Rosen HJ; Cummings J
    Ann Neurol; 2007 Feb; 61(2):92-6. PubMed ID: 17212357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological laughter: common vs. unusual aetiology and presentation.
    Arlazaroff A; Mester R; Spivak B; Klein C; Toren P
    Isr J Psychiatry Relat Sci; 1998; 35(3):184-9. PubMed ID: 9803683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of poststroke emotional incontinence with yokukansan, an Asian herbal medicine: report of two cases.
    Kajitani K; Kanba S
    J Am Geriatr Soc; 2012 Feb; 60(2):379-81. PubMed ID: 22332687
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of tetrabenazine induced depression by selective noradrenaline (norepinephrine) reuptake inhibition.
    Schreiber W; Krieg JC; Eichhorn T
    J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):550. PubMed ID: 10610387
    [No Abstract]   [Full Text] [Related]  

  • 9. Duloxetine for pathological laughing and crying.
    Ferentinos P; Paparrigopoulos T; Rentzos M; Evdokimidis I
    Int J Neuropsychopharmacol; 2009 Nov; 12(10):1429-30. PubMed ID: 19785915
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involuntary emotional expression disorder in Alzheimer's disease - psychopharmacotherapy aspects.
    Mimica N; Drmić S; Presecki P
    Psychiatr Danub; 2009 Sep; 21(3):425-8. PubMed ID: 19794369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological laughter in a patient with multiple sclerosis.
    Hoegerl C; Zboray S
    J Am Osteopath Assoc; 2008 Aug; 108(8):409-11. PubMed ID: 18723460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychologic aspects of multiple sclerosis.
    Schiffer RB; Rudick RA; Herndon RM
    N Y State J Med; 1983 Mar; 83(3):312-6. PubMed ID: 6574351
    [No Abstract]   [Full Text] [Related]  

  • 14. [4 years of clinical studies with minaprine in 85 neuropsychiatric cases].
    Faure H; Faure-Martinet ML; Sailhan M; Larue JY; Vie M; Seckler M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1979; 7(6):389-94. PubMed ID: 547721
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex.
    Feinstein A; O'Connor P; Gray T; Feinstein K
    Mult Scler; 1999 Apr; 5(2):69-73. PubMed ID: 10335513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worsening of borderline symptoms under reboxetine treatment.
    Anghelescu I; Jänen B; Schindler F; Lammers CH
    J Neuropsychiatry Clin Neurosci; 2005; 17(4):559-60. PubMed ID: 16388001
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychopharmacology for the clinician. Treating depression with selective norepinephrine reuptake inhibitors.
    Blier P
    J Psychiatry Neurosci; 2006 Jul; 31(4):288. PubMed ID: 16862246
    [No Abstract]   [Full Text] [Related]  

  • 18. Paroxysmal dystonia and pathological laughter as a first manifestation of multiple sclerosis.
    Aguirregomozcorta M; Ramió-Torrentà L; Gich J; Quiles A; Genís D
    Mult Scler; 2008 Mar; 14(2):262-5. PubMed ID: 17942514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pathologic laughter and crying in patients with locked-in syndrome: a report of 4 cases.
    Sacco S; Sarà M; Pistoia F; Conson M; Albertini G; Carolei A
    Arch Phys Med Rehabil; 2008 Apr; 89(4):775-8. PubMed ID: 18374012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction. Norepinephrine: neurotransmitter for the millennium.
    Nemeroff CB
    J Clin Psychiatry; 2000; 61 Suppl 10():3-4. PubMed ID: 10910011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.